VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Sep 4, 2007 -- Perceptronix Medical Inc. (Perceptronix) announced today they will present results from their clinical trial of LungSign(TM) at the 12th World Conference on Lung Cancer being held in Seoul, Korea September 2-6, 2007. Dr. David Snead, Consultant Pathologist at Walsgrave NHS Trust Hospital Coventry UK, will introduce the data during his oral presentation scheduled for September 2nd.
